Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery


      Objective: The aim of this study was to assess the impact of elective cesarean delivery on postpartum morbidity in women who are infected with the human immunodeficiency virus (HIV). Study design: We performed a retrospective study of 401 women who were infected with HIV who were delivered in a single reference center from 1989 through 1999. Women who had cesarean deliveries (n = 201), of which 109 were elective and 92 were emergency, were compared with a group of women who were delivered vaginally (n = 200), composed of the women who were infected with HIV preceding each cesarean delivery. Results: One or more serious complications occurred after 12% of emergency cesarean deliveries, after 6.4% of elective cesarean deliveries, and after 4% of vaginal deliveries (P = .04). In a multivariate analysis, which was adjusted for maternal CD4 lymphocyte count and antepartum hemorrhage, the relative risk of any postpartum complication (serious or minor) was increased by 1.85 (range, 1.00-3.39) after elective cesarean delivery and 4.17 (range, 2.32-7.49) after emergency cesarean delivery, compared with vaginal deliveries (P = .0001). Conclusion: Postpartum morbidity in women who are infected with HIV was highest after emergency, rather than elective, cesarean deliveries. (Am J Obstet Gynecol 2002;186:784-9.)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mandelbrot L
        • Le Chenadec J
        • Berrebi A
        • et al.
        Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort.
        JAMA. 1998; 280: 55-60
        • International Perinatal HIV Group
        The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: a meta-analysis of 15 prospective cohort studies.
        N Engl J Med. 1999; 340: 977-987
        • European Mode of Delivery Collaboration
        Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial.
        Lancet. 1999; 353: 1035-1039
        • American College of Obstetricians and Gynecologists, Committee on Obstetric Practice
        ACOG committee opinion: scheduled cesarean delivery and the prevention of vertical transmission of HIV infection: number 219, August 1999.
        Int J Gynaecol Obstet. 1999; 66: 305-306
        • Star J
        • Powrie R
        • Cu-Uvin S
        • Carpenter CC
        Should women with human immunodeficiency virus be delivered by cesarean?.
        Obstet Gynecol. 1999; 94: 799-801
        • Stringer JSA
        • Rouse DJ
        • Goldenberg RL
        Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission: the case for restraint.
        JAMA. 1999; 281: 1946-1949
        • Hall MH
        • Bewley S
        Maternal mortality and mode of delivery [letter].
        Lancet. 1999; 354: 776
        • Bulterys M
        • Chao A
        • Dushimana A
        • Saah A
        Fatal complications after cesarean section in HIV-infected women [letter].
        AIDS. 1996; 10: 923-924
        • Semprini AE
        • Castagna C
        • Ravizza M
        • et al.
        The incidence of complications after caesarean section in 156 HIV-positive women.
        AIDS. 1995; 9: 913-917
        • Maiques-Montesinos V
        • Cervera-Sanchez J
        • Bellver-Pradas J
        • Abad-Carrascosa A
        • Serra-Serra V
        Post-cesarean section morbidity in HIV-positive women.
        Acta Obstet Gynecol Scand. 1999; 78: 789-792
        • Rodriguez EJ
        • Spann C
        • Jamieson D
        • Lindsay M
        Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women.
        Am J Obstet Gynecol. 2001; 184: 1108-1111
        • Watson WJ
        • George RJ
        • Welter S
        • Day D
        High-risk obstetric patients: maternal morbidity after cesareans.
        J Reprod Med. 1997; 42: 267-270
        • Roman J
        • Bakos O
        • Cnattingius S
        Pregnancy outcomes by mode of delivery among term breech births: Swedish experience 1987-1993.
        Obstet Gynecol. 1998; 92: 945-950
        • Subtil D
        • Vaast P
        • Dufour P
        • Depret-Mosser S
        • Codaccioni X
        • Puech F
        Conséquences maternelles de la césarienne par rapport à la voie basse.
        J Gynecol Obstet Biol Reprod. 2000; 29: 10-16
        • Watts DH
        • Lambert JS
        • Stiehm ER
        • et al.
        Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of 500/μL.
        Am J Obstet Gynecol. 2000; 183: 100-107
        • Read J
        • Tuomala R
        • Kpamegan E
        • et al.
        Mode of delivery and postpartum morbidity among HIV-infected women: the Women and Infants Transmission Study.
        J Acquir Immune Defic Syndr. 2001; 26: 236-245
        • Grubert TA
        • Reindell D
        • Kastner R
        • et al.
        Complications after caesarean section in HIV-1-infected women not taking antiretroviral treatment.
        Lancet. 1999; 354: 1612-1613
        • Mandelbrot L
        • Landreau-Mascaro A
        • Rekacewicz C
        • et al.
        Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.
        JAMA. 2001; 285: 2083-2093
      1. Perinatal HIV Guidelines Working Group. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
        January 24, 2001 (Available at:)
        • Blanche S
        • Tardieu M
        • Rustin P
        • et al.
        Persistent mitochodrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.
        Lancet. 1999; 354: 1084-1099
        • Delfraissy JF
        • pour les groupes d'experts cliniciens et virologues
        prise en charge thérapeutique des personnes infectées par le VIH.
        : Flammarion, Paris (France)2000